Study reveals benign brain tumours can cause more emotional harm than malignant tumours

(Medical Xpress)—In a paper published in the Journal of Neuro-oncology, researchers have found that that patients with benign brain tumours experience greater distress than those with malignant tumours before radiation therapy

"Most would assume that a benign tumour would cause less distress in patients but these results show at early diagnosis this is the opposite. Participants with benign tumours showed substantially elevated distress relative to patients with a ," says lead researcher Dr Maria Kangas.

Researchers studied groups of patients diagnosed with a range of tumours and assessed their mood, stress and overall quality of life to measure the effects of on the psychosocial in adults.

Though patients with a benign brain tumour did report a decline in stress following (as did malignant brain tumour patients) these results are important to understand the range of emotional needs of patients with brain tumours.

"Quite often people feel that having a benign tumour is not as much of a problem but this isn't the case. Both benign and malignant tumors can be life-threatening and can cause impairments as well as psychosocial problems," says Dr Kangas.

Another interesting finding from the research was the difference in between patients with tumours in the left hemisphere of the brain compared to right hemisphere brain tumours.

"We found that patients with left hemisphere tumours were more susceptible to experiencing elevated stress and . This makes a lot of sense, as left hemisphere effects how we respond emotionally,' says Dr Kangas.

"These findings highlight the importance of screening for psychosocial and cognitive disturbances for patients with brain tumours undergoing treatment. It's crucial to identify patients who may be at risk of experiencing acute and more prolonged problems," say Dr Kangas.

According to the Brain Foundation, there are almost 1,400 new cases of malignant brain tumours in Australia with more than 1,200 people dying each year from malignant and benign brain tumours. The prevalence rates for clinical depression and anxiety have been found to be as high as 62.5% in adults treated for brain tumours.

The Macquarie University Cancer Institute has just launched a new brain tumour clinic and say this research is vital to the improving treatment for with brain tumours.

"It is vital to integrate psychological research into our programs and this is an important study," said Dr Andrew Davidson, lead clinician for neuro-oncology at Macquarie Cancer Institute.

"It's really scary when someone develops a brain tumour. It is not enough for a patient to have an operation; we need to look after them as a whole person and help them to deal with the difficult issues they face both emotional and physical," says Professor John Boyages, Director of the Macquarie University Cancer Institute (MCI).

"This is the advantage we have at the Macquarie University Hospital with a team of health professionals that includes a psychologist and expert nurses.

Related Stories

Genetic markers hope for new brain tumor treatments

Jun 15, 2012

Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for new diagnostic tools for a deadly type of brain tumour that mainly targets children.

A better diagnostic tool for brain cancer

Jun 07, 2012

A joint study by researchers at the National Neuroscience Institute (NNI), National University of Singapore (NUS), and Singapore Institute for Clinical Sciences (SICS), A*STAR, has uncovered the role of a new tumour suppressor ...

Recommended for you

New paper describes how DNA avoids damage from UV light

9 hours ago

In the same week that the U.S. surgeon general issued a 101-page report about the dangers of skin cancer, researchers at Montana State University published a paper breaking new ground on how DNA – the genetic code in every ...

Drug target identified for common childhood blood cancer

10 hours ago

In what is believed to be the largest genetic analysis of what triggers and propels progression of tumor growth in a common childhood blood cancer, researchers at NYU Langone Medical Center report that they have identified ...

User comments